Venture Advisor at Cultivation Capital
View Live Interactive Profile →David Narrow is listed on Cultivation Capital's team page with the title Venture Advisor. He is cofounder and Chief Executive Officer of Sonavex Inc., a Johns Hopkins University spin-out that his firm profile says has raised $24M in equity and $10M in federal grants and develops AI and deep learning enabled ultrasound products for surgical patients, one of which was recognised in TIME's Best Inventions of 2024. He previously founded MonoMano Inc., focused on rehabilitation for stroke survivors, and worked as a healthcare consultant at Health Advances LLC. He holds a B.S. in Biomedical Engineering with Highest Distinction from the University of Rochester and a master's degree from Johns Hopkins University, and holds multiple patents. A record was created for him despite the advisory title because the Form D for Cultivation Capital Life Sciences Fund IV, LP names him as a Director, Promoter and Managing Director of the fund's general partner, which is a partner-level decision-making role. Sonavex and MonoMano are companies he founded rather than investments attributed to him, so notableInvestments is empty.